Skip to main content
GRDN
NYSE Trade & Services

CFO Morris David K Sells Over $5.5M in Company Stock Amid Secondary Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$37.57
Mkt Cap
$2.379B
52W Low
$19.17
52W High
$38.12
52W Position info
96% above low
Off High info
1.4% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

GRDN sits 96% above its 52-week low of $19.17.

Summary

Guardian Pharmacy Services' CFO, Morris David K, sold 187,855 shares for over $5.5 million, participating in the company's recently finalized secondary offering.


Key Events · Ownership and Investor Activity · GRDN

  • CFO Sells Significant Stake

    Executive Vice President and CFO Morris David K sold 187,855 shares of Class A Common Stock for a total value of $5,576,006.

  • Part of Recent Secondary Offering

    The sale was executed on March 20, 2026, and is explicitly noted as being pursuant to the underwriting agreement for the secondary offering by selling stockholders, which was finalized on March 23, 2026.

  • Key Executive Disposition Near 52-Week High

    This transaction represents a notable disposition by a top executive, occurring while the company's stock is trading near its 52-week high, potentially indicating profit-taking.


Analysis · GRDN · Trade & Services

Executive Vice President and Chief Financial Officer Morris David K sold 187,855 shares of Guardian Pharmacy Services stock for over $5.5 million. This transaction, executed on March 20, 2026, was part of the secondary offering by selling stockholders, which was finalized on March 23, 2026. While the market was aware of the broader secondary offering, this Form 4 specifically details a substantial disposition by a key executive. The sale occurs as the stock trades near its 52-week high, suggesting the insider is taking profits following the company's recent strong financial performance.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GRDN was trading at $37.57 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $19.17 to $38.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRDN - Latest Insights

GRDN
Sep 01, 2026, 4:30 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $38.60
Real-time Price: $46.49 info
Change: +$7.89 (+20%) info
Market Cap: $2.945B info
GRDN
Aug 06, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.47
Real-time Price: $46.49 info
Change: +$7.02 (+18%) info
Market Cap: $2.945B info
GRDN
Jul 01, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $42.13
Real-time Price: $46.49 info
Change: +$4.36 (+10%) info
Market Cap: $2.945B info
GRDN
Jun 22, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.30
Real-time Price: $46.49 info
Change: +$5.19 (+13%) info
Market Cap: $2.945B info
GRDN
May 28, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $38.75
Real-time Price: $46.49 info
Change: +$7.74 (+20%) info
Market Cap: $2.945B info